INTERNATIONAL PATENT: MEMORIAL SLOAN-KETTERING CANCER CENTER, MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES, SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH FILES APPLICATION FOR "4- AMINOQUINOLINE INHIBITORS OF THE AUTOPHAGY-LYSOSOMAL PATHWAY (ALP) AS A THERAPEUTIC APPROACH FOR PANCREATIC CANCER"

GENEVA, March 11 -- MEMORIAL SLOAN-KETTERING CANCER CENTER (1275 York AvenueNew York, New York 10065), MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (1275 York AvenueNew York, New York 10065), SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (1275 York AvenueNew York, New York 10065) filed a patent application (PCT/US2025/044026) for "4- AMINOQUINOLINE INHIBITORS OF THE AUTOPHAGY-LYSOSOMAL PATHWAY (ALP) AS A THERAPEUTIC APPROACH FOR PANCREATIC CANCER" on Aug 28, 2025. With publication no. WO/2026/050552, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Orga...